The genome-editing technique Crispr used with stem cells is shown to release enzymes that reduce cocaine-seeking behavior in lab mice and protect against overdoses. . . . → Read More: Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses
|
|||||
A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes. . . . → Read More: Patents Awarded for Stem Cell Heart Disease Technologies 
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments  Comments are closed  Finance, Intellectual property  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, stem cells, university, venture capital 
A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders. . . . → Read More: Univ. Spin-Off Developing Myelin Disease Treatments Unveiled 2 comments - (Comments are closed) Finance, Intellectual property biomedical, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, stem cells, university, venture capital 
A university bioengineering group developed a model of a left ventricle, the heart chamber that pumps blood to the body, made with engineered heart muscle tissue to replace animals for drug testing. . . . → Read More: Tissue-Engineered Heart Chamber Model Developed One comment - (Comments are closed) New products biomedical, engineering, heart disease, life sciences, materials science, medical device, nanotechnology, patent, physical sciences, stem cells, university 
A tissue engineering team developed a process that includes computer-assisted design for personalized grafts derived from a patient’s own stem cells, to repair bone defects caused by trauma or disease. . . . → Read More: Computer-Aided Bone Graft Process Devised with Stem Cells One comment - (Comments are closed) New products biomedical, engineering, life sciences, materials science, medical device, pharmaceuticals, physical sciences, software, stem cells 
A genetics lab in the U.K. revealed that a leading technique for editing genomes produces more unwanted damage to the edited genomes than previously understood. . . . → Read More: More Damage Detected from Crispr-Cas9 Edits Comments are closed Regulations biomedical, biotechnology, Europe, genomics, life sciences, patent, pharmaceuticals, stem cells, U.K. 
A company developing therapies for brain injuries and neurodegenerative disorders is acquiring the rights to a process that treats these conditions with pieces of RNA transferred in tiny containers call exosomes. . . . → Read More: Exosome Technology Acquired for TBI, Stroke Therapies One comment - (Comments are closed) Intellectual property biomedical, biotechnology, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, stem cells 
Medical researchers and material scientists devised a technique for delivering tiny particles of genetic material to the brain, which help lab mice shrink or remove their brain tumors and survive longer. . . . → Read More: RNA Nanoparticles Designed for Brain Cancer Therapy Comments are closed New products biomedical, biotechnology, cancer, engineering, life sciences, materials science, nanotechnology, patent, pharmaceuticals, physical sciences, preclinical, stem cells, university 
Results from a clinical trial testing transplants of neural stem cells for spinal cord injuries show the therapies are safe for patients, with signs of improvement in most participants 1 to 2 years after treatment. . . . → Read More: Stem Cell Transplants Found Safe for Spinal Cord Injuries Comments are closed New products biomedical, biotechnology, clinical trials, life sciences, pharmaceuticals, stem cells, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
